• Company
    • About us
    • Team
    • Corporate Sustainability
    • Careers
    • Locations
    • Press Releases
  • Platform
    • Overview
    • Products
      • Life Science Products
        • Maestro
        • Glide
        • FEP+
        • LiveDesign
        View All
      • Materials Science Products
        • MS Maestro
        • LiveDesign
        • Desmond
        • Jaguar
        View All
    • Support
        • Documentation
        • Knowledge Base
        • My Cases
        • Python API
        • Known Issues
        Contact Support
    • Download
  • Life Science
    • Overview
    • Solutions
      • Solutions Overview

        Explore how Schrödinger solutions can solve research challenges across drug discovery application areas

      • Small Molecule Discovery
        • Structure Prediction & Target Enablement
        • Hit Discovery
        • Hit-to-Lead & Lead Optimization
        • Drug Formulation
      • Mixed Modalities
        • Antibody Design
        • Peptide Discovery
        • Enzyme Engineering
        • Bifunctional Degraders
        • TCR Modeling
      • Key Products & Services
        • Maestro
        • LiveDesign
        • FEP+
        • BioLuminate
        • Modeling Services
        View All Products
    • Use Cases
      • Use Cases Overview

        Explore how teams can apply Schrödinger technology to accomplish their work across industries

      • By Team Function
        • Computational Chemistry
        • Medicinal Chemistry
        • Research IT
        • Structural Biology
      • By Industry
        • Academics
        • Biotech & Pharmaceutical
      • Morphic Therapeutic leverages digital chemistry strategy to design a novel small molecule inhibitor of α4β7 integrinCase Study
        Morphic Therapeutic leverages digital chemistry strategy to design a novel small molecule inhibitor of α4β7 integrin
        View All Case Studies
    • Resources
      • Resources
        • Case Studies
        • Documentation
        • Events
        • Training Videos
        • Publications
        • Quick Reference Sheets
        • Tutorials
        • Webinars
        • White Papers
        View All Resources
    • Education
      • Education
        • Overview
      • Online Certification Courses
        • Introduction to molecular modeling in drug discovery
        • Introduction to computational antibody engineering
        • Free energy calculations for drug design with FEP+
        View All Online Courses
      • Teaching with Schrödinger
        • How It Works
        • Lessons & Worksheets
        • FAQs
        View curricula
  • Materials Science
    • Overview
    • Solutions
      • Solutions Overview

        Explore how Schrödinger solutions can solve research challenges across materials science application areas

      • By Application
        • Polymeric Materials
        • Organic Electronics
        • Energy Capture & Storage
        • Thin Film Processing
        • Catalysis & Reactivity
        • Consumer Packaged Goods
        • Metals, Alloys, & Ceramics
        • Pharmaceutical Formulations & Delivery
      • Key Products & Services
        • MS Maestro
        • Desmond
        • Jaguar
        • LiveDesign
        • Services & Collaborations
        View All Products
    • Use Cases
      • Use Cases Overview

        Explore how teams can apply Schrödinger software to accomplish their work across industries

      • By Industry
        • Academics
        • Aerospace
        • Automotive
        • Biotech & Pharmaceuticals
        • Consumer Packaged Goods
        • Oil & Gas
        • Semiconductor
        • Specialty Chemicals
      • By Team Function
        • Computational Chemistry
        • Experimental Chemistry
        • Materials Engineering
        • Research IT
      • Molecular dynamics and coarse-grained simulations facilitate the design of new eco-friendly cosmetic formulationsCase Study
        Molecular dynamics and coarse-grained simulations facilitate the design of new eco-friendly cosmetic formulations
        View All Case Studies
    • Resources
      • Resources
        • Case Studies
        • Documentation
        • Events
        • Training Videos
        • Publications
        • Quick Reference Sheets
        • Tutorials
        • Webinars
        • White Papers
        View All Resources
    • Education
      • Education
        • Overview
      • Online Certification Courses
        • Pharmaceutical formulations
        • Homogeneous catalysis and reactivity
        • Consumer packaged goods
        VIEW ALL ONLINE COURSES
      • Teaching with Schrödinger
        • How it Works
        • Lessons & Worksheets
        • FAQs
        View curricula
  • Pipeline
    • Overview
    • Clinical Programs
      • Proprietary Pipeline Highlights
        • SGR-1505 (MALT1)SGR-1505 is a mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitor.
        • SGR-3515 (Wee1/Myt1)SGR-3515 is a Wee1/Myt1 inhibitor.
      • Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia
        Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia
        Schrödinger Reports Encouraging Initial Phase 1 Clinical Data for SGR-1505 at EHA Annual Congress
        Schrödinger Reports Encouraging Initial Phase 1 Clinical Data for SGR-1505 at EHA Annual Congress
  • Investors
My AccountLogoutMy Account
PaymentLogout
Login
Contact Us

On achieving high accuracy and reliability in the calculation of relative protein-ligand binding affinities

Posted on September 7, 2018January 23, 2025 by Anonymous
Posted in Small Molecule Drug DiscoveryLeave a Comment on On achieving high accuracy and reliability in the calculation of relative protein-ligand binding affinities

Replica Exchange with Solute Scaling: A more efficient version of Replica Exchange with Solute Tempering (REST2)

Posted on September 7, 2018December 10, 2024 by Anonymous
Posted in UncategorizedLeave a Comment on Replica Exchange with Solute Scaling: A more efficient version of Replica Exchange with Solute Tempering (REST2)

How To Deal with Multiple Binding Poses in Alchemical Relative Protein-Ligand Binding Free Energy Calculations

Posted on September 7, 2018January 23, 2025 by Anonymous
Posted in Hit Discovery, Small Molecule Drug DiscoveryLeave a Comment on How To Deal with Multiple Binding Poses in Alchemical Relative Protein-Ligand Binding Free Energy Calculations

Accurate and Reliable Prediction of the Binding Affinities of Macrocycles to Their Protein Targets

Posted on September 7, 2018January 23, 2025 by Anonymous
Posted in Hit Discovery, Small Molecule Drug DiscoveryLeave a Comment on Accurate and Reliable Prediction of the Binding Affinities of Macrocycles to Their Protein Targets

Pyrido[4,3-e][1,2,4]triazolo[4,3-a]pyrazines as Selective, Brain Penetrant Phosphodiesterase 2 (PDE2) Inhibitors

Posted on September 7, 2018January 23, 2025 by Anonymous
Posted in Small Molecule Drug DiscoveryLeave a Comment on Pyrido[4,3-e][1,2,4]triazolo[4,3-a]pyrazines as Selective, Brain Penetrant Phosphodiesterase 2 (PDE2) Inhibitors

Application of Free Energy Perturbation for the Design of BACE1 Inhibitors

Posted on September 7, 2018January 23, 2025 by Anonymous
Posted in Hit Discovery, Small Molecule Drug DiscoveryLeave a Comment on Application of Free Energy Perturbation for the Design of BACE1 Inhibitors

Computational Macrocyclization: From de novo Macrocycle Generation to Binding Affinity Estimation

Posted on September 7, 2018January 23, 2025 by Anonymous
Posted in Hit Discovery, Small Molecule Drug DiscoveryLeave a Comment on Computational Macrocyclization: From de novo Macrocycle Generation to Binding Affinity Estimation

Examining the Feasibility of Using Free Energy Perturbation (FEP+) in Predicting Protein Stability

Posted on September 7, 2018January 23, 2025 by Anonymous
Posted in Biologics Drug Discovery, Peptide DiscoveryLeave a Comment on Examining the Feasibility of Using Free Energy Perturbation (FEP+) in Predicting Protein Stability

Relative binding affinity prediction of farnesoid X receptor in the D3R Grand Challenge 2 using FEP+

Posted on September 7, 2018January 23, 2025 by Anonymous
Posted in Small Molecule Drug DiscoveryLeave a Comment on Relative binding affinity prediction of farnesoid X receptor in the D3R Grand Challenge 2 using FEP+

Acylguanidine Beta Secretase 1 Inhibitors: A Combined Experimental and Free Energy Perturbation Study

Posted on September 7, 2018January 23, 2025 by Anonymous
Posted in Hit Discovery, Hit-to-Lead & Lead Optimization, Small Molecule Drug DiscoveryLeave a Comment on Acylguanidine Beta Secretase 1 Inhibitors: A Combined Experimental and Free Energy Perturbation Study

Free Energy Calculation Guided Virtual Screening of Synthetically Feasible Ligand R-Group and Scaffold Modifications: An Emerging Paradigm for Lead Optimization

Posted on September 7, 2018December 10, 2024 by Anonymous
Posted in Hit Discovery, Hit-to-Lead & Lead OptimizationLeave a Comment on Free Energy Calculation Guided Virtual Screening of Synthetically Feasible Ligand R-Group and Scaffold Modifications: An Emerging Paradigm for Lead Optimization

Advancing Drug Discovery through Enhanced Free Energy Calculations

Posted on September 7, 2018January 23, 2025 by Anonymous
Posted in Hit Discovery, Hit-to-Lead & Lead Optimization, Small Molecule Drug Discovery, Structure Prediction & Target EnablementLeave a Comment on Advancing Drug Discovery through Enhanced Free Energy Calculations

Posts navigation

Older posts
Newer posts

Ready to release the power of digital chemistry?

Contact us
Schrödinger
  • Platform
  • Products
  • Life Science
  • Materials Science
  • Pipeline
  • Download
  • Company
  • Locations
  • Team
  • Education
  • Login or Create Account
    Logout
  • Contact Support
  • Contact Sales
  • Instagram
  • LinkedIn
  • Privacy Policy
  • Terms of use
  • EULA
  • Other Terms and Policies
Copyright © 2026 Schrödinger, Inc.